(Q30996713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Francesca Giampieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

Francesca Pistollato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Sandra Sumalla Cano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Manuel Masias Vergara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Maurizio Battino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

Journal of Alzheimer's Disease

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

303-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Alzheimer disease models and human neuropathology: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Development of positron emission tomography β-amyloid plaque imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Advances of molecular imaging probes for the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Amyloid imaging: the court of public opinion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Insulin resistance predicts brain amyloid deposition in late middle-aged adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Impaired glycemia increases disease progression in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Cardiovascular Risk Factors for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Alzheimer's disease and epigenetic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Diet, cognition, and Alzheimer's disease: food for thought

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Utility of imaging for nutritional intervention studies in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Maximizing the Alzheimer's Disease Neuroimaging Initiative II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Diet and Neuroimaging Markers of Cerebrovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Disorders of "taste cognition" are associated with insular involvement in patients with Alzheimer's disease and vascular dementia: "memory of food is impaired in dementia and responsible for poor diet".

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

The chemical senses and nutrition in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Aroma and taste perceptions with Alzheimer disease and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Taste in mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

A functional neuroimaging study of appetite loss in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Brain metabolic dysfunction at the core of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a resting-state fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Insulin resistance and gray matter volume in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Low cerebral blood flow is associated with lower memory function in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Homocysteine effects on brain volumes mapped in 732 elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Nutritional status determinants and cognition in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Mediterranean diet, Alzheimer disease, and vascular mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Physical activity, diet, and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Nutrition, brain aging, and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Plasma lipids and cerebral small vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Total antioxidant capacity of the diet and major neurologic outcomes in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Adipokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Dietary restriction in cerebral bioenergetics and redox state

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Calorie restriction reduces psychological stress reactivity and its association with brain volume and microstructure in aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Resveratrol as a therapeutic agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Regular fish consumption and age-related brain gray matter loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Vitamin E in neurodegenerative disorders: Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Food sources of nitrates and nitrites: the physiologic context for potential health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Acute effect of a high nitrate diet on brain perfusion in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome: The SUN prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150301

21 January 2018

Identifiers

DOI

10.3233/JAD-150301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401997%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference